WallStSmart

Solowin Holdings (AXG)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 28313811% more annual revenue ($2.17T vs $7.66M). NMR leads profitability with a 16.7% profit margin vs -90.3%. NMR earns a higher WallStSmart Score of 70/100 (B-).

AXG

Avoid

31

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 6.0
Piotroski: 2/9Altman Z: -1.33

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AXG3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
295.8%10/10

Revenue surging 295.8% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

AXG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$657.07M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.3%3/10

Operating margin of 0.3%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : AXG

The strongest argument for AXG centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 295.8% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : AXG

The primary concerns for AXG are EPS Growth, Market Cap, Operating Margin.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

AXG profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

AXG is growing revenue faster at 295.8% — sustainability is the question.

AXG generates stronger free cash flow (-569,179), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 31/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Solowin Holdings

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Solowin Holdings, an investment holding company, provides corporate finance, wealth management, virtual assets, and asset management services in Hong Kong. The company is headquartered in Tsim Sha Tsui, Hong Kong.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?